Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4792

1.

How to Deal with Non-Extractable TIPS Complicating Liver Transplantation.

Gilbo N, Ceulemans LJ, Maleux G, Nevens F, Laleman W, Jochmans I, Monbaliu D, Pirenne J.

Liver Transpl. 2018 Jun 22. doi: 10.1002/lt.25209. [Epub ahead of print] No abstract available.

PMID:
29931729
2.

Liver preservation solutions: "Absence of proof is not proof of absence…".

Adam R, Cailliez V, Segev D, Karam V.

Liver Transpl. 2018 Jun 19. doi: 10.1002/lt.25208. [Epub ahead of print] No abstract available.

PMID:
29923365
3.

Pro: Steroids can be withdrawn posttransplant in recipients with autoimmune hepatitis.

Kalra A, Burton JR, Forman L.

Liver Transpl. 2018 Jun 19. doi: 10.1002/lt.25206. [Epub ahead of print] Review.

PMID:
29923302
4.

Lymphocyte-to-Monocyte Ratio is a Predictor of Survival after Liver Transplantation for Hepatocellular Carcinoma.

Mano Y, Yoshizumi T, Yugawa K, Ohira M, Motomura T, Toshima T, Itoh S, Harada N, Ikegami T, Soejima Y, Maehara Y.

Liver Transpl. 2018 Jun 12. doi: 10.1002/lt.25204. [Epub ahead of print]

PMID:
29893464
5.

Con: Steroids should not be withdrawn in transplant recipients with autoimmune hepatitis.

Theocharidou E, Heneghan MA.

Liver Transpl. 2018 Jun 12. doi: 10.1002/lt.25205. [Epub ahead of print] Review.

PMID:
29893056
6.

Inflexion of the curve: Hepatitis C's waning role in liver transplantation.

Martin P.

Liver Transpl. 2018 Jun;24(6):727-728. doi: 10.1002/lt.25201. No abstract available.

PMID:
29878534
7.

Predictors of ultrasound failure to detect hepatocellular carcinoma.

Samoylova ML, Mehta N, Roberts JP, Yao FY.

Liver Transpl. 2018 May 21. doi: 10.1002/lt.25202. [Epub ahead of print]

PMID:
29781162
8.

Aspirin and Statin Use for Management of Atherosclerotic Cardiovascular Disease in Liver Transplant Candidates: Are We Missing the Mark?

VanWagner LB.

Liver Transpl. 2018 May 21. doi: 10.1002/lt.25203. [Epub ahead of print] No abstract available.

PMID:
29781097
9.

Survival Outcomes in Split Compared to Whole Liver Transplantation.

Yoon KC, Song S, Jwa EK, Lee S, Kim JM, Kim OK, Hong SK, Yi NJ, Lee KW, Kim MS, Hwang S, Suh KS, Lee SK.

Liver Transpl. 2018 May 10. doi: 10.1002/lt.25196. [Epub ahead of print]

PMID:
29747216
10.

Reply to Letter "Liver preservation solutions: Absence of proof is not proof of absence".

Hameed AM, Laurence JM, Lam VWT, Pleass HC, Hawthorne WJ.

Liver Transpl. 2018 May 9. doi: 10.1002/lt.25195. [Epub ahead of print] No abstract available.

PMID:
29742806
11.

Palliative Care in End-Stage Liver Disease: Time to do better?

Mazzarelli C, Prentice WM, Heneghan MA, Belli LS, Agarwal K, Cannon MD.

Liver Transpl. 2018 May 5. doi: 10.1002/lt.25193. [Epub ahead of print] Review.

PMID:
29729119
12.

Transplantation's cooperative future.

Lobritto SJ.

Liver Transpl. 2018 Jun;24(6):729-730. doi: 10.1002/lt.25192. No abstract available.

PMID:
29729118
13.

Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence following Transplantation.

Welling TH, Eddinger K, Carrier K, Zhu D, Kleaveland T, Moore DE, Schaubel DE, Abt PL.

Liver Transpl. 2018 May 5. doi: 10.1002/lt.25194. [Epub ahead of print]

PMID:
29729113
14.

The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia-reperfusion injury.

Liss KHH, McCommis KS, Chambers KT, Pietka TA, Schweitzer GG, Park SL, Nalbantoglu I, Weinheimer CJ, Hall AM, Finck BN.

Liver Transpl. 2018 May 5. doi: 10.1002/lt.25189. [Epub ahead of print]

PMID:
29729104
15.

Is portal venous pressure modulation still indicated for all recipients in living-donor liver transplantation?

Yao S, Kaido T, Uozumi R, Yagi S, Miyachi Y, Fukumitsu K, Anazawa T, Kamo N, Taura K, Okajima H, Uemoto S.

Liver Transpl. 2018 Apr 30. doi: 10.1002/lt.25180. [Epub ahead of print]

PMID:
29710397
16.

Antitumor effect of sorafenib and mTOR inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence.

Jung DH, Tak E, Hwang S, Song GW, Ahn CS, Kim KH, Moon DB, Ha TY, Park GC, Ryoo BY, Lee KJ, Kim N, Kwon JH, Jwa EK, Lee SG.

Liver Transpl. 2018 Apr 30. doi: 10.1002/lt.25191. [Epub ahead of print]

PMID:
29710388
17.

Morphological characterization of chronic antibody mediated rejection in ABO-identical or compatible pediatric liver graft recipients.

Dao M, Habès D, Taupin JL, Mussini C, Redon MJ, Suberbielle C, Jacquemin E, Gonzales E, Guettier C.

Liver Transpl. 2018 Apr 27. doi: 10.1002/lt.25187. [Epub ahead of print]

PMID:
29704327
18.

Can we minimize wait-list mortality in young children with Biliary atresia?

Schlegel A, Muiesan P.

Liver Transpl. 2018 Jun;24(6):731-732. doi: 10.1002/lt.25190. No abstract available.

PMID:
29704300
19.

Fatigue, Pain, and other Physical Symptoms of Living Liver Donors in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL-2).

Butt Z, DiMartini AF, Liu Q, Simpson MA, Smith AR, Zee J, Gillespie BW, Holtzman S, Ladner D, Olthoff K, Fisher RA, Hafliger S, Freise CE, Mandell MS, Sherker AH, Dew MA.

Liver Transpl. 2018 Apr 26. doi: 10.1002/lt.25185. [Epub ahead of print]

PMID:
29698577
20.

Reply to Letter to the Editor by Patrono et al. (LT-18-211), concerning manuscript: Normothermic Machine Perfusion of Donor Livers Without the Need for Human Blood Products (LT-17-589.R2).

Matton APM, de Vries Y, Porte RJ.

Liver Transpl. 2018 Apr 25. doi: 10.1002/lt.25183. [Epub ahead of print] No abstract available.

PMID:
29694712

Supplemental Content

Loading ...
Support Center